Cooper Simon Peter 4
4 · Keros Therapeutics, Inc. · Filed Jan 25, 2022
Insider Transaction Report
Form 4
Cooper Simon Peter
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-21+50,000→ 50,000 totalExercise: $46.30Exp: 2032-01-20→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the option shall vest on January 19, 2023, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.